麝香保心丸联合复方血栓通胶囊治疗经皮冠状动脉介入术术后短期冠脉慢血流的临床分析

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Shexiang Baoxin Pills combined with Compound Xueshuantong Capsules in the treatment of short-term coronary slow blood flow (CSF)after percutaneous coronary intervention(PCI).Methods The clinical data of 60 patients with short-term CSF after PCI who were admitted to Jiangxi Provincial People′s Hospital from January 2016 to November 2020 were retrospectively analyzed.According to different treatment methods,the patients were divided into the experiment group (34 cases)and the control group (26 cases).The control group was treated with Nicorandil,and the experimental group was treated with Shexiang Baoxin Pills combined with Compound Xueshuantong Capsules.Both groups were treated consecutively for one month.The treatment effect after treatment,the improvement of clinical symptoms before and after treatment,the serum tumor necrosis factor-α (TNF-α)and high-sensitivity C-reactive protein(hs-CRP)levels were compared between the two groups.Results The total clinical effective rate in the experiment group was higher than that in the control group,and the difference was statistically significant(P＜0.05).There were no statistically significant differences in the duration of chest pain,the frequency of chest pain episodes,the levels of serum TNF-α and hs-CRP before treatment between the two groups (P＞0.05).After treatment,the duration of chest pain in the two groups were shorter than those before treatment,and the experimental group was shorter than that of the control group,the differences were statistically significant(P＜0.05).The frequency of chest pain,serum TNF-α and hs-CRP levels in the groups were lower than those before treatment,and the experimental group was lower than that of the control group,the differences were statistically significant (P＜0.05).Conclusion Shexiang Baoxin Pills combined with Compound Xueshuantong Capsules can effectively relieve the clinical symptoms of patients with short-term CSF after PCI,reduce the level of serum inflammatory factors,and improve the therapeutic effect.

Key words： Coronary slow blood flow Shexiang Baoxin Pills Compound Xueshuantong Capsules Percutaneous coronary intervention Tumor necrosis factor-&alpha High-sensitivity C-reactive protein

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Xue-hong
	ZENG Lin-fei
	CHEN Bin

Cite this article:

ZHANG Xue-hong,ZENG Lin-fei,CHEN Bin. Clinical analysis on Shexiang Baoxin Pills combined with Compound Xueshuantong Capsules in the treatment of short-term coronary slow blood flow after percutaneous coronary intervention[J]. 中国当代医药, 2021, 28(31): 60-62转66.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I31/60

[1]	邢雨蒙，孔德红，陈永乐，等.实时心肌超声造影定量评价冠脉慢血流患者心肌血流灌注[J].中华超声影像学杂志2018，27（4）：277-281.
[2]	马春朋，刘晓丽，王庆胜，等.急性胸痛缺血风险评分模型的建立和验证[J].中华心血管病杂志，2018，46（2）：131-136.
[3]	张红刚，周敏，李达，等.西洛他唑联合尼可地尔对LEAOD患者baPWV、ABI指数及CD36水平的影响[J].东南大学学报（医学版），2018，37（6）：1014-1018.
[4]	苏锦锋，杨凡，邓莉，等.复方血栓通胶囊对冠心病患者PCI术后心肌微循环的影响[J].现代中西医结合杂志，2019，28（32）：3601-3604.
[5]	何永福，孙林，林志.冠状动脉慢血流现象病理生理机制及治疗进展[J].心血管病学进展，2018，39（3）：150-154.
[6]	郭海鹏，魏燕.PCI术前口服高剂量阿托伐他汀对STEMI病人术后冠状动脉血流和血尿酸、炎症介质的影响[J].中西医结合心脑血管病杂志，2018，16（7）：100-103.
[7]	关欣，刘毅，陶凌，等.冠状动脉慢血流患者的随访性研究[J].现代生物医学进展，2018，18（7）：1278-1282.
[8]	乔俭.乔振纲论癌症治疗的中医思路和对策[J].中医学报，2019，258（11）：123-126.
[9]	崔光卫，邵洁，刘闯，等.针刺郄门穴改善冠脉慢血流现象28 例即时效应观察[J].中国针灸，2020，376（1）：47-48.
[10]	吴帮卫，李剑，金波，等.麝香保心丸促血管新生的机制[J].中成药，2018，40（6）：1384-1388.
[11]	刘宏，生书晶，李沛波，等.复方血栓通胶囊对弥散性血管内凝血模型大鼠炎症抑制作用及机制研究[J].中南药学，2019，165（10）：35-39.
[12]	李慧，李丹丹，吴珠，等.复方血栓通胶囊治疗冠心病急性心肌梗死临床疗效观察[J].中国中医急症，2020，270（10）：154-156.
[13]	张庆红，张克民，谷洪燕.麝香保心丸联合瑞舒伐他汀治疗冠心病心绞痛临床疗效及对血液流变学、血脂的影响[J].中华中医药学刊，2018，36（7）：1777-1779.
[14]	高文慧，徐梦，马青，等.复方血栓通胶囊对脑缺血再灌注小鼠神经可塑性的影响[J].北京中医药大学学报，2019，42（5）：378-388.
[15]	吴香丽，谢赟，殷英霞，等.复方血栓通胶囊联合曲安奈德球后注射辅助全视网膜光凝治疗糖尿病黄斑水肿疗效分析[J].陕西中医，2018，39（6）：736-738.
[16]	景丽英，郑俊华.麝香保心丸联合倍他乐克对冠心病心绞痛患者心电图及心功能指标的影响[J].中国医药科学，2021，11（14）：71-74.
[17]	张伟，梅益斌，喻晖.麝香保心丸预防糖尿病患者冠脉支架术后再狭窄的临床效果分析[J].中国现代医生，2019，57（26）：115-118.